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Peripheral tolerance is crucial for avoiding activation
of self-reactive T cells to tissue-restricted antigens.
Sterile tissue injury can break peripheral tolerance,
but it is unclear how autoreactive T cells get activated
in response to self. An example of a sterile injury is
myocardial infarction (MI). We hypothesized that tis-
sue necrosis is an activator of dendritic cells (DCs),
which control tolerance to self-antigens. DC subsets
of a murine healthy heart consisted of IRF8-depen-
dent conventional (c)DC1, IRF4-dependent cDC2,
and monocyte-derived DCs. In steady state, cardiac
self-antigen a-myosin was presented in the heart-
draining mediastinal lymph node (mLN) by cDC1s,
driving the proliferation of antigen-specific CD4+
TCR-M T cells and their differentiation into regulatory
cells (Tregs). Following MI, all DC subsets infiltrated
the heart, whereas only cDCs migrated to the mLN.
Here, cDC2s induced TCR-M proliferation and dif-
ferentiation into interleukin-(IL)-17/interferon-(IFN)g-
producing effector cells. Thus, cardiac-specific
autoreactive T cells get activated by mature DCs
following myocardial infarction.
INTRODUCTION
Autoreactive CD4+ T cells are normally deleted during thymic
negative selection, yet many self-reactive T cells escape this
checkpoint, emerging as anergic, thymic regulatory (tTreg) or
ignorant conventional T cells (Tconv) (Davis, 2015). Self-reactive
T cell activation is a major culprit in autoimmune disease, and
therefore tolerance to some tissue-restricted self-antigens is
shaped entirely by extrathymic processes. Suppression of autor-
eactive CD4+ T cells is dependent on peripheral dendritic cells
(DCs), which present tissue-restricted self-antigens derived
mostly from turnover of apoptotic cells (Steinman et al., 2003).Cell R
This is an open access article under the CC BY-NIn the absence of inflammation, self-antigen presentation by
DCs results in T cell anergy, further expansion of tTregs, or gen-
eration of induced (i)Tregs from Tconv cells, thus promoting pe-
ripheral tolerance to the self-antigen (Ganguly et al., 2013). Lack
of steady-state DCs results in loss of functional Tregs and
subsequent activation of autoreactive Th1/Th17 effector cells,
whereas increased numbers of immature DCs result in increased
iTreg numbers, which prevent autoimmunity (Ohnmacht et al.,
2009; Darrasse-Je`ze et al., 2009). It is, however, equally impor-
tant that DCs presenting self-antigen remain in a quiescent state,
devoid of cytokine production that can break peripheral toler-
ance (Eriksson et al., 2003; Ardouin et al., 2016). Removal of
inhibitory nuclear factor (NF)-kB signaling intermediates or artifi-
cial extension of DC life-span are sufficient to break self-toler-
ance (Kool et al., 2011; Stranges et al., 2007). Despite experi-
ments clearly implicating DCs in the regulation of peripheral
tolerance and induction of autoimmunity, the precise triggers
that cause DC activation and possibly break self-tolerance are
incompletely understood (Ganguly et al., 2013). Certain organ-
directed infections trigger tissue-specific autoimmunity by pro-
moting DC activation either through direct infection or release
of cytokines that cause full DC maturation (Gangaplara et al.,
2012; Torchinsky et al., 2009). Endogenous danger signals like
uric acid or HMGB1 lead to DC maturation in response to sterile
tissue injury (Scaffidi et al., 2002). Exposure of DCs to necrotic
cells is sufficient to drive DC maturation in vitro (Gallucci et al.,
1999). But currently, it is not known if sterile inflammation
induced by tissue ischemia and necrosis causes DCs to drive
the initiation of adaptive immune responses to self-antigen
in vivo.
To address this, we chose a model of myocardial infarction
(MI). Undoubtedly, tissue necrosis caused by coronary artery oc-
clusion is one of the most common diseases of Western society,
causing significant mortality and morbidity (Latet et al., 2015). MI
results in necrotic cardiomyocytes releasing their intracellular
contents, which act as danger signals that cause sterile inflam-
mation (Zhang et al., 2015). In healthy mice and humans, CD4+
T cells specific for cardiac self-antigen a-myosin heavy chain
(aMyHC) escape thymic negative selection and seed theeports 18, 3005–3017, March 21, 2017 ª 2017 The Author(s). 3005
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
periphery, rendering the heart vulnerable to an autoimmune
attack (Lv et al., 2011). Up to 30% of MI patients develop signs
of humoral autoimmunity that is often self-limiting but can
be accompanied by pericarditis. This percentage increases to
80% of autoimmune prone type I diabetes (T1D) patients. Non-
obese diabetic (NOD) mice, a mousemodel of T1D, also develop
pathologic cardiac autoimmunity post MI, whereas wild-type
(WT) C57BL/6 mice do not (Gottumukkala et al., 2012; Lipes
and Galderisi, 2015). Environmental cues from an infarcted heart
are thus sufficient to induce heart-specific immunity in autoim-
mune prone hosts in the absence of microbial ligands. It was hy-
pothesized before that the innate inflammatory response in the
infarcted heart can initiate the maturation of DCs, licensing
them for activation of T cells directed against the heart (Gottu-
mukkala et al., 2012; Lv and Lipes, 2012); however, direct evi-
dence of this DC-T cell interaction post MI is lacking. To study
if danger signals released by tissue injury can activate DCs and
generate adaptive immunity, TCR transgenic mice (TCR-M)
have been developed to measure CD4+ T cell responses to
aMyHC (Nindl et al., 2012). Using these tools, we studied if,
where, and how cardiac self-antigens are presented. In steady
state, conventional type 1 DCs (cDC1s) presented cardiac self-
antigen to aMyHC-specific TCR-M cells only in heart-draining
mediastinal lymph nodes, leading to Treg expansion. In mice in
which MI was induced, cardiac DCs were activated and in vivo
aMyHC presentation was increased. Post MI, mainly conven-
tional type 2 DCs (cDC2s) presented aMyHC and induced the
formation of interferon (IFN)g- and interleukin (IL)-17-producing
TCR-M cells. These findings show that tissue necrosis activates
autoreactive T cells through DC maturation and migration.
RESULTS
CD11c-Expressing Cells in the Heart Can Be Subdivided
into cDC1s, cDC2s, and moDCs
Conventional DCs,which form thecrucial link between innate and
adaptive immunity, are divided into two subsets termed cDC1s
and cDC2s (Guilliams et al., 2014). cDCs arise in a Flt3L-depen-
dent manner from progenitors in the bone marrow (Waskow
et al., 2008), andare dividedbasedon surfacemarkers anddiffer-
ential dependence on transcription factors (TFs) (Sichien et al.,
2017). cDC1s express XCR1 and CD103 and depend on Batf3
and IRF8, whereas cDC2s express CD172a (SIRPa) and CD11b
and partially depend on Zeb2 and IRF4 (Bajan˜a et al., 2012; Scott
et al., 2016). Because DC subsets in the murine heart are poorly
defined, we characterized subsets in the healthy heart. We
used flow cytometry to identify CD11c+ cells among live non-
autofluorescent CD45+ Lineage cells. These were further
divided based on MHCII and CD64 to identify MHCII+CD64
cDCs and CD64+MHCII+ monocyte-derived DCs (moDCs) (Fig-
ure 1A). Embryonically derived macrophages (MFs) were out-
gated because these cells are autofluorescent and do not ex-
press CD11c (Molawi et al., 2014; Epelman et al., 2014). cDCs
can be further subdivided into XCR-1+ cDC1s and CD172a+
cDC2s, whereas moDCs uniformly expressed CD172a. CD11c+
cells made up 0.98% ± 0.27% (mean ± SEM) of all living heart
cells and 7.39% ± 1.36% of CD45+ leukocytes. cDC1s and
cDC2s made up 4.77% ± 0.16% and 14.5% ± 1.25% of3006 Cell Reports 18, 3005–3017, March 21, 2017total CD11c-expressing cells, respectively, whereas 16.87% ±
3.09% of CD11c+ cells were moDCs (Figures 1B and 1C). cDC
development depends on Flt3L, whereas moDC development
does not (Waskow et al., 2008). So to confirm cDC and moDC
identification, hearts of Flt3l/ mice were compared with
Flt3+/+ hearts. We found a severe reduction in cDC1s and
cDC2s in the Flt3l/ heart compared with WT mice, whereas
moDCs were unaffected (Figures 1D and 1E), demonstrating
that only heart cDCs are Flt3L dependent. We next examined
the expression of surface markers associated with DC subsets
(Figures 1F and 1G). Cardiac cDC subsets expressed the typical
cDC markers CD26 (Miller et al., 2012) and Flt3. As described in
other tissues, cDC2s and moDCs expressed CD11b, whereas
cDC1s expressed CD103. cDC1s uniformly expressed CD24,
whereas cDC2s were separated into CD24+ and CD24 cDC2s,
as described for lung cDC2s (Bajan˜a et al., 2016). Expression of
CADM1, a universal cDC1 marker (Guilliams et al., 2016; Gurka
et al., 2015), was restricted to cDC1s. MoDCs expressed the
typical MF markers MerTK, Mar-1, and F4/80, although some
F4/80 expression was also noted on cDC2s, as found in other
tissues (Tamoutounour et al., 2013). As expected, moDCs ex-
pressed CCR2, which is critical for monocyte exit from the
bone marrow. CCR2 was also expressed on cDCs, as observed
in intestinal cDC2s (Scott et al., 2015).
We next FACS-purified cDC1s, cDC2s, moDCs, and CD11c
MFs from a steady-state heart and performed RNA-sequencing
(RNA-seq) analysis (Figures 1H and 1I). To confirm identification
of heart cDC1s and cDC2s, we generated a list of hallmark genes
across a range of tissues by examining the transcriptomes
of cDC subsets available from the Immgen consortium. Gene
expression in cardiac APC populations was then studied. Car-
diac cDC1s indeed expressed cDC1 genes, including Clec9a,
Cadm1, Itgae, Tlr3, and Irf8, whereas these genes were lowly ex-
pressed by cardiac cDC2s, moDCs, and MFs (Figure 1H). cDC2
genes like Cd11b, Cd72, Csf1r, Zeb2, and Irf4 were highly ex-
pressed by cardiac cDC2s compared with cDC1s (Figure 1I).
Taken together, these data highlight the previously unappreci-
ated heterogeneity among cardiac DCs.
Transcription Factor Dependency of Cardiac cDC
Subsets
The molecular requirements for cardiac DC development have
been poorly studied. Because cDC1s and cDC2s in other tissues
are thought to depend on IRF8 and IRF4, respectively (Mildner
and Jung, 2014), we hypothesized that this would be the same
for cardiac cDCs. Therefore, we first examined IRF8 and IRF4
expression in cardiac DCs at the protein level (Figures 2A and
2B). IRF4 was most highly expressed by cardiac cDC2s,
whereas cDC1s expressed high levels of IRF8. Next, we crossed
mice expressing CRE recombinase under the control of the
CD11c promoter (Cd11cCremice) (Caton et al., 2007) with Irf4flox
(Persson et al., 2013) or Irf8flox mice (Sichien et al., 2016) to
generate mice lacking IRF4 or IRF8 expression, respectively, in
CD11c+ cells. Whenever CRE was expressed in CD11c+ cells,
Irf4 or Irf8 was efficiently floxed out and their protein levels
declined (data not shown). Analysis of Irf4fl/fl.Cd11cCre mice re-
vealed that cardiac cDC2 (CD172a+CD24+/) were only slightly
reduced (Figures 2C and 2E). However, a significant reduction
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Figure 1. CD11c-Expressing Cells in the Heart Can Be Subdivided into cDC1s, cDC2s, and moDCs
(A) Flow cytometry gating strategy for DC subsets in steady-state heart of WT mice.
(B) Pie chart representing the distribution of DC subsets in naive murine WT heart.
(C) DC subset percentages of total CD11c+ cells in naive heart of WT mice.
(D) Expression of MHCII and CD64 in CD45+LineageCD11c+ cells from naive heart in Flt3l+/+ and Flt3l/ mice.
(E) Total cDC, cDC1, cDC2, and moDC percentages of total living cells in naive heart of Flt3l+/+ and Fltl3/ mice.
(F) Representative histograms of CD26, Flt3, CD11b, CD103, CD24, CADM1, MerTK, Mar-1, CCR2, and F4/80 expression in steady-state WT heart cDC1s,
cDC2s, and moDCs (n = 3).
(G) MFI of marker expression on steady-state WT heart DC subsets shown in (F).
(H and I) Heat map of relative expression of (H) hallmark cDC1 genes and (I) hallmark cDC2 genes in cDC1s, cDC2s,moDCs, andMFs sorted from naiveWT hearts
acquired by RNA-seq. All data in Figure 1 represent at least two independent experiments, and all bar graphs show data as mean ± SEM (*p% 0.05).in CD24+ cDC2s was observed, suggesting that IRF4 is impor-
tant for their terminal differentiation, as described in the lung (Ba-
jan˜a et al., 2016). Because IRF4 has also been implicated in regu-
lating cDC2 migration (Bajan˜a et al., 2012), we next studied
cDC2 frequency in the heart-draining mediastinal lymph node
(mLN) (Figures 2D and 2E). Migration of both CD24+ and
CD24 cDC2s was indeed lower in the mLN of Irf4fl/fl.Cd11cCre
mice. Examination of cDC subsets in the heart and mLN of
Irf8
fl/fl
.Cd11cCre mice demonstrated an almost complete abla-tion of cDC1s (CD24+CD172a) in both locations (Figures 2F–
2H). cDC2s were unaffected in the Irf8fl/fl.Cd11cCre heart, but
were significantly increased in the mLN. Thus, cardiac cDC1s
and cDC2s, similarly to their counterparts in other organs,
depend on IRF8 and IRF4, respectively, for their development
(cDC1s and CD24+ cDC2s) and migration to the lymph nodes
(LNs) (cDC2s). Thus, Irf8fl/fl.Cd11cCre and Irf4fl/fl.Cd11cCre
mice represent two models in which cardiac cDC1 and cDC2
function, respectively, can be assessed.Cell Reports 18, 3005–3017, March 21, 2017 3007
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Figure 2. Transcription Factor Dependency of Cardiac cDC Subsets
(A) Representative histogram of IRF4 and IRF8 expression of steady-state WT heart cDC1s, cDC2s, and moDCs.
(B) MFI of IRF4 and IRF8 expression on naive WT heart DC subsets shown in (A).
(C and D) MHCII+CD11c+CD64 cDCs are divided into CD24+CD172a cDC1s, CD24+CD172a+ cDC2s, and CD24CD172a+ cDC2s in Irf4fl/fl and
Irf4fl/fl.Cd11cCre steady-state heart (C) and mediastinal LN (D).
(E) Percentage of living cells of cDCs in Irf4fl/fl and Irf4fl/fl.Cd11cCre naive heart and mLN.
(F and G) MHCII+CD11c+CD64 cDCs are divided into CD24+CD172a cDC1s, CD24+CD172a+ cDC2s, and CD24CD172a+ cDC2s in Irf8fl/fl and
Irf8fl/fl.Cd11cCre steady-state heart (F) and mLN (G).
(H) Percentage of living cells of cDCs in Irf8fl/fl and Irf8fl/fl.Cd11cCre steady-state heart and mLN. All data in Figure 2 represent at least two independent ex-
periments, and all bar graphs show data as mean ± SEM (*p% 0.05).IRF8-Dependent cDC1s Generate Myosin-Specific
Tregs in Heart-Draining Lymph Node
Although the heart is not continuously exposed to environmental
antigens compared with mucosal surfaces, heart DCs can
encounter cardiac self-antigens, such as a-myosin heavy chain
(aMyHC). Because aMyHC autoreactive CD4+ T cells escape
from the thymus into the periphery (Lv et al., 2011), it is plausible
that cardiac DCs would function in preserving peripheral toler-
ance to the heart. Thus, we next examined if cardiac cDC1s or
cDC2s played such a role. A critical tool to answer this key ques-
tion was aMyHC-specific TCR-M mice (Nindl et al., 2012). Naive
CD62L+CD44 CD4+ T cells were purified from TCR-M spleno-
cytes, CFSE labeled, and injected into steady-state WT litter-
mates (Irf4fl/fl and Irf8fl/fl mice without Cd11cCre expression) to
determine if and where aMyHC is presented. Various lymphoid
organs of acceptor mice were collected for analysis 3 days after3008 Cell Reports 18, 3005–3017, March 21, 2017TCR-M transfer. Undivided TCR-M cells were present in all or-
gans examined, consistent with the migratory behavior of naive
T cells (Figures 3A and 3D). TCR-M proliferation detected by
CFSE dilution and CD44 expression was exclusively observed
in the heart-draining mediastinal LN of naive WT mice. TCR-M
proliferation and activation in mLN demonstrated aMyHC trans-
port and presentation without the presence of cardiac damage
(Figures 3B and 3E). Upon division, TCR-M cells gained expres-
sion of T-bet and RoRgt, respectively, and TFs for Th1 and Th17
cells (Figures 3C and 3F). Divided cells also expressed Foxp3
and CD25 indicative for Tregs (Figures 3C and 3F). To verify if
migratory cDC2s were responsible for aMyHC presentation in
mLN, naive TCR-M cells were injected in Irf4fl/fl.Cd11cCre
mice. TCR-M cells in Irf4fl/fl.Cd11cCre mLN proliferated equally
well as in WT littermates, indicating that cDC2 migration is not
necessary for aMyHC presentation (Figures 3A and 3B). T-bet,
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Figure 3. IRF8-Dependent cDC1s Generate Myosin-Specific Tregs in Heart-Draining Lymph Node
(A) Depicted LNs and spleen were isolated from TCR-M acceptor Irf4fl/fl and Irf4fl/fl.Cd11cCre mice 3 days after naive TCR-M transfer. CFSE dilution and CD44
expression of donor TCR-M cells was analyzed by flow cytometry.
(B) Percentage of proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from the experiment described in (A) (n = 4).
(C) Percentage of T-bet, RoRgt, and Foxp3/CD25 expression on undivided and divided donor TCR-M cells isolated from mLN in Irf4fl/fl and Irf4fl/fl.Cd11cCre
steady-state mice (n = 4).
(D) 3 days after naive TCR-M injection, depicted LNs and spleen were isolated from TCR-M acceptor Irf8fl/fl and Irf8fl/fl.Cd11cCremice. CFSE dilution and CD44
expression of donor TCR-M cells was analyzed by flow cytometry.
(E) Percentage of proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from the experiment described in (D) (n = 5).
(F) Percentage of T-bet, RoRgt, and Foxp3/CD25 expression on undivided and divided donor TCR-M cells isolated from mLN in Irf8fl/fl and Irf8fl/fl.Cd11cCre
steady-state mice (n = 5). All data in Figure 3 represent at least three independent experiments, and bar graphs show data as mean ± SEM (*p% 0.05).RoRgt, and Foxp3 increase upon division was unchanged in
Irf4fl/fl.Cd11cCre mLN compared with Irf4fl/fl (Figure 3C). Naive
TCR-M cells were next administered to Irf8fl/fl.Cd11cCre mice
to study if cDC1s were responsible for steady-state aMyHC pre-
sentation. Proliferation and CD44 expression was significantly
lower in mLN of Irf8fl/fl.Cd11cCre mice compared with Irf8fl/fl
mice 3 days post-transfer (Figures 3D and 3E). Although T-bet
and RoRgt upregulation in divided TCR-M cells was not altered
in Irf8fl/fl.Cd11cCremLN (Figure 3F), Foxp3 induction was signif-
icantly reduced in divided TCR-M cells from Irf8fl/fl.Cd11cCre
mLN, showing a block in iTreg generation in the absence of
cDC1s. Our findings identify cardiac cDC1s as necessary for
aMyHC-specific Treg induction from naive TCR-M cells.
DCs Infiltrate the Heart and Migrate to the Mediastinal
Lymph Node Following MI
MI triggers an inflammatory response characterized by infiltra-
tion of innate immune cells (Latet et al., 2015). Although infiltra-tion of DCs has been described in infarcted hearts (Maekawa
et al., 2009), DC subsets have not been identified. Thus, we first
sought to characterize DC subsets postMI.We inducedMI inWT
female mice by permanently ligating the left anterior descending
(LAD) coronary artery and examined DCs at various time points
post-surgery. Consistent with previous reports, the proportion
of CD11c+ cells was increased compared with sham-operated
controls (Figure 4A). A significant part of CD11c+ cells in MI
hearts was CD64+MHCII. These cells were not further analyzed
because they lacked MHCII expression. They are probably MFs
recruited due to MI, as seen in other sterile inflammation models
(Zigmond et al., 2014). At day 7 post-surgery, we also observed a
dramatic increase in moDCs (CD64+CD172a+) in MI hearts
compared to sham (Figures 4A and 4B). Analysis of DC subsets
between 2 and 10 days post MI revealed an increase of all sub-
sets by day 2 post MI, with the peak of XCR-1+ cDC1 and moDC
infiltration at day 7. CD172a+ cDC2 numbers peaked at day 5
post MI. moDCs contributed most to the total infarcted heartCell Reports 18, 3005–3017, March 21, 2017 3009
0 103 104 105
0
103
104
105 9.55
0 103 104 105
0
103
104
105 27.7
1.9
30.3
0 103 104 105
0
103
104
105 7.39
25.6
51.9
0 103 104 105
0
103
104
105 22.7
0 103 104 105
0
102
103
104
105
1.780.741
0 103 104 105
0
102
103
104
105
5.550.614
MHCII
C
D
11
c
MHCIIhiMHCIIint MHCIIMHCII
int hi
mLN sham d7 mLN MI d7
C
A B
C
D
11
c
CD172α
C
D
11
c
CD172α
M
H
C
II
CD64
M
H
C
II
CD64
CD11c+
CD11c+
cDC moDC
cDC moDC
Heart
sham d7
Heart
MI d7
D
E
F
H
G
day 2 day 5 day 7 day 10 day 2 day 5 day 7 day 10 day 2 day 5 day 7 day 10
Heart cDC1 Heart cDC2 Heart moDC
Ab
so
lu
te
 c
el
l n
um
be
r
Ab
so
lu
te
 c
el
l n
um
be
r
Ab
so
lu
te
 c
el
l n
um
be
r
sham MI d2 MI d5 MI d7 MI d10
cDC1
cDC2
moDC
0.0
5.0 103
1.0 104
1.5 104
*
*
**
0
1 103
2 103
3 103
*
*
**
0
2 103
4 103
6 103
8 103 *
*
**
0
1 104
2 104
3 104
sham
MI
*
**
Heart cDC
Ab
so
lu
te
 c
el
l n
um
be
r
day 2 day 5 day 7 day 10
H
ea
rt
MHCII
%
of
 liv
in
g
ce
lls
Mediastinal LN
0.00
0.05
0.10
0.15
0.20
0.25
sham d7
MI d7
Mesenteric LN
%
of
 liv
in
g
ce
lls
hi DCs MHCIIhi DCs
0.0
0.2
0.4
0.6
*
m
LN
sham MI d2 MI d5 MI d7 MI d10
MHCII   cDC1
MHCII   cDC2
MHCII   moDC
hi
hi
hi
MHCII   cDC1
MHCII   cDC2
MHCII   moDC
MHCII   cDC
hi
hi
hi
int
CCR7
%
 o
f m
ax
mLN MI d.7
0 103 104 105
0
20
40
60
80
100
0.0
0.2
0.4
0.6
%
 o
f l
iv
in
g 
ce
lls
*
*
*
mLN MHCII   DChi
day 2 day 5 day 7 day 10
0.00
0.02
0.04
0.06
0.08
0.10 *
*
0.0
0.1
0.2
0.3
0.4
*
*
0.00
0.02
0.04
0.06
0.08
*
*
**
*
sham
MI
mLN MHCII   cDC1hi mLN MHCII   cDC2hi mLN MHCII   moDChi
day 2 day 5 day 7 day 10 day 2 day 5 day 7 day 10 day 2 day 5 day 7 day 10
%
 o
f l
iv
in
g 
ce
lls
%
 o
f l
iv
in
g 
ce
lls
%
 o
f l
iv
in
g 
ce
lls
Figure 4. DCs Infiltrate the Heart and Migrate to Mediastinal Nodes Following MI
(A) Representative gating strategy for DC subsets in the heart of sham-operated and infarcted WT mice on day 7 post-surgery.
(B) Absolute cell numbers of DC subsets in the heart of sham-operated and infarcted mice on day 2, 5, 7, and 10 post-surgery (n = 3–6).
(C) Pie charts depicting the distribution of DC subsets in the sham-operated heart (pooled data from day 2-5-7-10 post-surgery) and infarcted heart on day 2, 5, 7,
and 10 post-MI. Pie chart sizes are proportional to total cardiac DC percentages.
(D) Representative gating strategy for MHCIIint and MHCIIhi DCs in mediastinal LN of sham-operated and infarcted WT mice on day 7 post-surgery.
(E) MHCIIhi DC percentages of total living cells in mediastinal and mesenteric LN in sham-operated and infarcted mice at day 7 post-surgery (n = 6).
(F) MHCIIhi DC subset percentages of total living cells in mediastinal LN of sham-operated and infarcted mice on day 2, 5, 7, and 10 post-surgery (n = 3–6).
(G) Pie chart illustrating distribution of cDC1s, cDC2s, andmoDCs among total MHCIIhi DC population in mLN in sham-operated and infarcted mice at day 2, 5, 7,
and 10 post-surgery. Pie chart sizes are proportional to total MHCIIhi DCs in mLN.
(H) Representative histogram of CCR7 expression of MHCIIhi cDC1s, MHCIIhi cDC2s, MHCIIhi moDCs, and MHCIIint cDCs from mLN on day 7. All bar graphs in
Figure 4 show data as mean ± SEM (*p% 0.05; **p% 0.01), and all data are representative of two independent experiments.DC population. All subsets returned to near baseline levels within
10 days (Figures 4B and 4C). Next, we studied migration to the
heart-draining mediastinal LN post MI. Typically, DCs that have
migrated to the LN from the periphery are MHCIIhi, in contrast
to LN-resident DCs that are MHCIIint. An increase in MHCIIhi
DCs was observed in mediastinal, but not mesenteric, LNs
7 days post MI compared with sham (Figures 4D and 4E). Among
MHCIIhi DCs, we identified XCR-1+ cDC1s, CD172a+ cDC2s,
and CD64+moDCs.We followed DCmigration to themediastinal
LN between 2 and 10 days post-surgery (Figures 4F and 4G).
Consistent with heart DC infiltration, MHCIIhi DC subsets peaked
at day 7 post MI. MHCIIhi cDC2s represented the largest DC
population. To validate if DCs had indeed migrated from the
heart, we examined CCR7 expression, the chemokine receptor
required for migration to the LN (Ohl et al., 2004). As expected,3010 Cell Reports 18, 3005–3017, March 21, 2017MHCIIhi cDC1s and cDC2s expressed CCR7 and hence
migrated to the LN, whereas MHCIIint cDCs lacked CCR7 (Fig-
ure 4H). However, MHCIIhi moDCs did not express CCR7, sug-
gesting that moDCs have not migrated from the heart and
instead have merely upregulated MHCII, as has been reported
(Tamoutounour et al., 2013).
DCs from Infarcted Heart Have an Activated Phenotype
To gain more insight in the phenotype of DCs infiltrating the
infarcted heart, we performed RNA-seq on heart cDC1s,
cDC2s, andmoDCs sorted from post MI day 7 hearts. As a refer-
ence population, we also sorted cardiac CD11c MFs (Linea-
geCD11cMHCII+CD64+CD172a+). Unsupervised principle-
component analysis (PCA) showed that irrespective of the heart
tissue environment (steady state or MI), cardiac DCs clustered
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Figure 5. DCs from Infarcted Heart Have an Activated Phenotype
(A) Front view of PCA of RNA-seq data from cDC1s, cDC2s, moDCs, andMFs in the steady-state (St St) and the infarcted (MI d7) heart. PCAwas calculated using
the top 15% most varying genes between cell subsets. Each dot symbolizes one independently sorted replicate of the indicated cell population, and four
independent sorts were performed per subset.
(B and C) Heat map of relative expression of hallmark cDC1 genes (B) and hallmark cDC2 genes (C) in cDC1s, cDC2s, moDCs, andMFs sorted from steady-state
and infarcted hearts.
(D) Side view of PCA of RNA-seq data from cDC1s, cDC2s, moDCs, and MFs in the steady-state and infarcted heart.
(E) Venn diagram showing numbers and overlap of DEGs in cDC1s, cDC2s, and moDCs sorted from MI d7 compared to steady-state hearts.
(F) Heat map of relative expression of top-shared DEGs between DC subsets from MI d7 hearts compared to corresponding subsets isolated from the steady-
state heart. To calculate top DEGs, a threshold of aminimum1.5 Log2 fold change was used. As an exception, no threshold was set on shared upregulated genes
of cDC1s, cDC2s, and moDCs.
(G) Bar graphs representing absolute expression of DEGs among cDC1s, cDC2s, and moDCs sorted from steady-state and infarcted hearts.
(H) MFI of CD40 and CD86 expression (day 7 post-surgery) on heart DC subsets in sham-operated compared to the infarcted heart (n = 6). All bar graphs in
Figure 5 show data as mean ± SEM (*p% 0.05; **p% 0.01), and all data are representative of four independent experiments.
See also Figure S1 and Tables S1–S7.bysubsetonprincipal components 1 (pc1) and2 (pc2) (Figure5A).
Also, expression of hallmark cDC1 (Figure 5B) and cDC2 genes
(Figure 5C) did not change in cardiac DCs post MI. Interestingly,
pc3 divided cell subsets into two groups, those deriving from the
steady state or infarcted heart (Figure 5D), suggesting a globalMI
signature, which was conferred upon the subsets post MI. To
further examine the MI signature, gene expression of infarcted
heart DCs was compared with that of steady-state heart
DCs to identify differentially expressed genes (DEGs). We found
that 395, 700, and 326 genes were differentially expressed in
cDC1s, cDC2s, and moDCs, respectively, between healthy and
infarcted hearts (Figure 5E; Tables S1–S3). To determine the
global MI signature, we assessed which DEGs were conserved
between DC subsets and found that 54 genes were differentially
expressed in the three DC subsets (Figures 5E and 5F; Table S4).
Analysis of these 54 genes suggested that DC subsets would be
altered in their activation status. Htr7 (encoding serotonin recep-
tor 5-HT7R) and Mmp14 (encoding metalloproteinase MMP-14)
were both upregulated in MI and are linked to DC migration (Fig-
ures 5F and 5G; complete DEG lists can be found in the Supple-mental Information; Tables S5–S7) (Holst et al., 2015; Gawden-
Bone et al., 2010). Smpdl3b (encoding sphingomyelin phospho-
diesterase, acid-like 3B) was downregulated and encodes a
negative regulator of TLR signaling (Heinz et al., 2015), suggest-
ing increased TLR signaling in post MI DCs. Recently, several
gene clusters were found to be induced upon homeostatic
or TLR-induced cDC1 maturation (Ardouin et al., 2016). We
observed that cDC1s fromMI hearts were enriched for genes up-
regulated by TLR-induced maturation, suggesting that cDC1s in
infarcted hearts were indeed induced to mature in a TLR-depen-
dent manner (Figures S1A and S1D). cDC2s andmoDCs fromMI
hearts were enriched in genes upregulated by TLR-induced and
homeostatic maturation (Figures S1B S1D).
To determine if DCs were also activated at the protein level
post MI, expression of the activation markers CD40 and CD86
was examined by flow cytometry during the peak of DC infiltra-
tion (day 7). As predicted by RNA-seq, the ischemic environment
induced DC activation. All DC subsets showed increased
expression of CD40 post MI (Figure 5H). However, CD86 expres-
sion was only increased on cDC2s from infarcted hearts.Cell Reports 18, 3005–3017, March 21, 2017 3011
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Figure 6. cDC2s Are the Main Presenters of aMyHC to Effector Autoreactive CD4+ T Cells Ex Vivo
(A) CFSE dilution andCD25 expression of TCR-M cells in co-culture with sorted heart DC subsets from sham-operated versusMI d7mice. Data are representative
of three independent experiments (n = 12).
(B) Quantification of percentages of proliferated and CD25-expressing TCR-M cells from co-cultures plotted in (A). Individual dots represent the value of one
independent experiment (mean ± SEM; *p% 0.05).
(C) Percentage of T-bet, RoRgt, and Foxp3/CD25 expression on TCR-M cells co-cultured with sorted heart DC subsets from MI day 7 hearts (mean ± SEM).
(D) In supernatants of co-cultures plotted in (A), cytokines produced by TCR-M cells were detected by ELISA. Mean is calculated from values of technical
replicates from one experiment (nd, not detectable) (mean ± SD).
(E) CFSE dilution and CD25 expression of TCR-M cells co-cultured with sorted migratory cDC1s and cDC2s frommLNs of sham-operated andMI mice and from
mesenteric LNs of MI mice.
(F) After 3 days of co-culture (plotted in E), cytokines were measured in supernatants by ELISA. Mean is calculated from values of technical replicates from one
experiment (nd, not detectable) (mean ± SD).
(G) Heat map of relative expression of cDC2 genes exclusively upregulated in cDC2s from the infarcted heart compared to steady state.
(H) Bar graphs representing absolute expression of interesting unique cDC2 DEGs (mean ± SEM; *p% 0.05).
See also Table S8.cDC2s Are the Main Presenters of aMyHC to Effector
Autoreactive CD4+ T Cells Ex Vivo
Having shown that DCs infiltrate the heart, adopt an activated
phenotype post MI, and migrate to mLN, we next examined
if they presented the cardiac self-antigen aMyHC, released
from necrotic cardiomyocytes to autoreactive T cells. To this
end, we sorted cDC1s, cDC2s, and moDCs from the heart at
day 7 post MI and sham controls and co-cultured them
ex vivo with TCR-M cells. Consistent with cDC2s being supe-
rior at presenting antigen to CD4+ T cells and with their mature
state post MI, proliferation and activation of TCR-M cells was
increased when co-cultured with cDC2s from MI hearts
compared with cDC1s and moDCs (Figures 6A and 6B). None-
theless, cDC1s and moDCs from the MI heart induced more
TCR-M proliferation compared to subsets from the sham heart
(Figure 6A). Fitting with the highest proliferation, TCR-M cells
cultured with heart cDC2s post MI exhibited increased expres-
sion of T-bet, RoRgt, and Foxp3 (Figure 6C) and the highest3012 Cell Reports 18, 3005–3017, March 21, 2017IFNg and IL-17 production (Figure 6D). Migratory cDC2s sorted
from mLN 7 days post MI were similarly best at inducing
TCR-M proliferation, whereas migratory cDC1s only activated
TCR-M cells (Figures 6E and 6F). Importantly, neither migratory
cDCs from sham mLN nor migratory cDCs from mesenteric LN
post MI stimulated TCR-M cells. To look further into the mech-
anisms of cDC2 superiority, we returned to our RNA-seq anal-
ysis. Using a stringent cut off described in the Supplemental
Experimental Procedures, the list of cDC2 DEGs (MI compared
to steady state) was reduced from 477 to 31 (Table S8). 15
DEGs were upregulated (Figure 6G), including Cst7 (encoding
cystatin F) and Klrb1f (encoding killer cell lectin-like receptor
subfamily B member 1F) (Figure 6H), which encode proteins
involved in antigen processing on MHCII (Magister et al.,
2012) and T cell stimulation, respectively (Tian et al., 2005).
This provides a plausible mechanism for the increased ability
of cDC2s from the infarcted heart to present aMyHC to
TCR-M cells.
Myocardial Infarction Activates Autoreactive CD4+ T
Cells In Vivo
Having shown that MI induces cardiac self-antigen presentation
by DCs ex vivo, we next sought to examine if MI would activate
autoreactive T cells in vivo. Therefore, naive TCR-M cells were
transferred to MI and sham mice 2 and 7 days post-surgery
and proliferation was analyzed 3 days later. TCR-M proliferation
was increased inmLNofmice injectedat day 2postMI compared
with sham, in vivo demonstrating increased aMyHCpresentation
early post MI (Figures 7A and 7B). TCR-M cells transferred to
mice at day 2 post MI did not upregulate CD25 and Foxp3 Treg
markers in mLN compared to sham mLN (Figure 7C). This sug-
gests that iTreg differentiation was blunted after MI, potentially
leading to a break in self-tolerance to the heart. Remarkably,
TCR-M cells also proliferated in non-heart-draining lymphoid or-
gans like the spleen and mesenteric LNs of MI mice compared
with sham at day 2 (Figures 7A and 7B). This could suggest early
systemic release of aMyHC post MI, which is presented by cDCs
in non-draining lymphoid organs. Alternatively, divided TCR-M
cells in non-draining LNs could be recirculating TCR-M cells
that originally divided in mLN. To address this, an ex vivo co-cul-
turewas set upwith bulk LN cells from shamd2,MI d2, andMI d7
mice as the antigen source and naive TCR-M cells as the readout
for antigen presence (Figure 7D). TCR-M cells exclusively prolif-
erated in the presence of mLN cells from MI d2 and d7 mice
and not with mesenteric LN and spleen cells, suggesting that
aMyHC is not systemically released in sufficiently high amounts
post MI to stimulate TCR-M cells in this in vitro setting.
Presentation of Cardiac Myosin in the Absence of cDC
Subsets following MI
Having demonstrated that self-antigen is presented to autoreac-
tive T cells both ex vivo and in vivo, with cDC2s appearing to be
specialized in this, we next set out to determine which cDC sub-
sets were necessary and/or sufficient for presenting aMyHC
post MI. We opted to use Irf4fl/fl.Cd11cCre and Irf8fl/fl.Cd11cCre
mice. Although loss of IRF4 did not decrease cDC2 populations
in the sham and MI heart, migratory cDC2s in the mLNs were
significantly reduced (Figure 7E); thus, these mice could be
used to assess the role of migratory cDC2s post MI. Naive
TCR-M cells were then transferred to Irf4
fl/fl
.Cd11cCre mice
2 days post MI. Intriguingly, decrease in migratory cDC2s in
mLN of Irf4fl/fl.Cd11cCremice did not affect TCR-M proliferation
and activation compared with Irf4fl/fl mice (Figures 7F and 7G),
demonstrating that cDC2s are not necessary. To examine if
cDC1s are needed, we performed the same experiment in
Irf8fl/fl.Cd11cCre mice because they lack cDC1s in the heart
and mLN in both sham and MI mice (Figure 7H and data
not shown). cDC1 loss had little effect on TCR-M proliferation
and activation (Figure 7I). Proliferation was slightly reduced
compared with Irf8fl/fl controls but was still 80%. So neither
cDC1s nor cDC2s are specifically required for the presentation
of aMyHC to autoreactive CD4+ T cells post MI.
DISCUSSION
It is widely accepted that DCs play a role in both the regulation of
peripheral tolerance and induction of autoimmunity. However,the exactmechanisms that causeDCactivation and hence break
tolerance remain to be dissected. One proposed mechanism is
the maturation of DCs by necrotic cells (Gallucci et al., 1999);
however, because this study was performed in vitro, it remains
unclear if and how tissue necrosis would contribute to the initia-
tion of autoimmunity in vivo. In this study, we addressed this
issue using MI as a model of tissue necrosis. Intracellular con-
tents released from necrotic cardiomyocytes can behave like
danger signals, resulting in a sterile inflammatory response
(Zhang et al., 2015). Prior to profiling the effects of MI on cardiac
DCs, we performed a comprehensive analysis of distinct DC
populations during homeostasis. Similar to other tissues, the
steady-state heart contains a population of CD11c+MHCII+ cells,
which we termed DCs. Further analysis led us to conclude that
heart DCs could be divided into two populations of conventional
DCs, termed cDC1s and cDC2s (Guilliams et al., 2014), and a
population CD64+CD11c+MHCII+, which we termed moDCs, in
line with what these cells were called previously (Tamoutounour
et al., 2013). There is considerable controversy surrounding the
correct name for this latter population because it is unclear if
they are a bona fide DC population or a type of macrophage
(Guilliams et al., 2016; Wu et al., 2016). Indeed, moDCs did
not migrate from the heart to the LN, a hallmark of genuine
DCs. However, moDCs did induce CD4+ T cell proliferation in
ex vivo co-cultures to the same extent as cDC1s and higher
than CD11c MFs (data not shown). Principal component anal-
ysis of gene expression also demonstrated that moDCs segre-
gate in between cDCs and MFs. Thus, the exact nature and
nomenclature of these cells remains unclear.
Because aMyHC-specific autoreactive CD4+ T cells escape
the thymus, peripheral tolerance is essential to prevent a cardiac
autoimmune attack (Lv et al., 2011). Although cardiac DCs have
been proposed to play a role in self-tolerance (Hart and Fabre,
1981), migration of self-antigen-loaded DCs to the draining LN
had not been experimentally verified. Here, we demonstrated
that naive aMyHC-reactive TCR-M cells proliferated in the
heart-draining mLN without inducing cardiac damage and that
they partially adopted an iTreg phenotype. It has recently been
shown that cDC1s and cDC2s can induce iTregs in mesenteric
LNs, with redundancy observed in mice lacking either cDC1s
or cDC2s (Esterha´zy et al., 2016). Accordingly, while observing
a reduction in iTreg generation in mLNs of steady-state
Irf8fl/fl.Cd11cCremice, the lack of cDC1s did not disrupt cardiac
tolerance (unpublished data). We speculate that there is some
redundancy among cardiac cDC subsets, which prevents auto-
immunity in the absence of cDC1s.
Consistent with studies examining all DCs (Anzai et al., 2012;
Zhang et al., 1993), we observed a significant yet transient
increase in cardiac DC subsets post MI. RNA-seq analysis
revealed that although heart cDC subsets retained their hall-
mark genes, the ischemic environment induced some changes
compared with steady-state DCs. Analysis of DEGs identified a
core MI signature, proposing that DCs from the infarcted heart
had amore activated phenotype. Analysis of maturation markers
confirmed this at the protein level. This is consistent with reports
demonstrating that necrotic cardiomyocytes release danger sig-
nals, including Hsp70 (Maekawa et al., 2009), interleukin-1a, and
HMGB-1 (Zhang et al., 2015), which can promote DC activationCell Reports 18, 3005–3017, March 21, 2017 3013
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Figure 7. Myocardial Infarction Activates Autoreactive CD4+ T Cells In Vivo
(A) TCR-M cells were injected into sham or MI mice on day 2 or day 7 post-surgery. CFSE dilution and CD44 expression of donor TCR-M cells is shown.
(B) Proliferation of donor TCR-M cells in lymphoid organs from the experiment described in (A).
(C) Percentage of Foxp3/CD25 expression on undivided and divided donor TCR-M cells isolated from mLN in sham and MI mice at day 2 post-surgery.
(D) CFSE dilution and CD44 expression of naive TCR-M cells in ex vivo co-culture with bulk mediastinal LN, spleen, and mesenteric LN cells isolated from sham
and MI mice on day 2 and day 7 post-surgery.
(E) Heart cDC2 and migratory cDC2 percentages in mLN of sham and MI Irf4fl/fl and Irf4fl/fl.Cd11cCre mice at day 7 post-surgery.
(F) Irf4fl/fl, Irf4fl/fl.Cd11cCre, Irf8fl/fl and Irf8fl/fl.Cd11cCre mice were injected with TCR-M cells at day 2 post MI. CFSE dilution and CD44 expression of donor
TCR-M cells is shown.
(G) Proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from Irf4fl/fl and Irf4fl/fl.Cd11cCre mice from the experiment described in (F).
(H) Heart cDC percentages of sham and MI Irf8fl/fl and Irf8fl/fl.Cd11cCre mice at day 7 post-surgery.
(I) Proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from Irf8fl/fl and Irf8fl/fl.Cd11cCremice from the experiment described in (F). All bar
graphs in Figure 7 show data as mean ± SEM (*p% 0.05; **p% 0.01; ***p% 0.001), and all data are representative of two independent experiments.
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by inducing Toll-like/interleukin-1 receptor signaling. Cardio-
myocyte necrosis also results in the release of cardiac self-anti-
gens, such as myosin and troponin, which are constrained in the
healthy heart (Larue et al., 1991). Thus, hypothetically, heart DCs
become activated via TLR stimulation by danger signals after MI
and get loaded with self-antigen, licensing DCs for the activation
of self-antigen-specific autoreactive T cells. Indeed, we found
that DCs from the infarcted heart and mLN presented cardiac
self-antigen to autoreactive CD4+ T cells, which adopted a
Th1/Th17 effector phenotype. This suggests that ischemic heart
injury leads to cardiac autoimmunity by acting on the DC activa-
tion state. Post-infarct autoimmunity is commonly observed,
with one-third of patients showing a proliferative response to
cardiac myosin (Moraru et al., 2006). Furthermore, post-infarct
autoimmunity contributes to persistent myocardial inflammation,
leading to further damage with pathological consequences (Got-
tumukkala et al., 2012). Early after MI (day 2), TCR-M cells prolif-
erated vigorously in heart-drainingmLN and, interestingly, also in
non-heart draining LNs, which could suggest systemic release of
self-antigen post MI due to massive destruction of cardiomyo-
cytes, which is captured by LN-resident DCs. However, we did
not observe a significant proliferation of TCR-M cells when co-
cultured with bulk spleen or mesenteric LN cells, suggesting
that either no systemic aMyHC release occurred or the quantity
of self-antigen in the circulation was too low to activate TCR-M
cells ex vivo. The proliferated TCR-M cells in distant LNs could
possibly also represent recirculating cells that had divided in
the heart-draining mLN after their first division.
Among DCs, cDC2s were the main subset activating autor-
eactive CD4+ T cells post MI and inducing IL-17a and IFNg
in TCR-M cells. Despite this, cDC2s may not be necessary
because TCR-M cells also proliferated in the mLN of
Irf4fl/fl.Cd11cCre mice, which have a severe reduction in migra-
tory cDC2s. Unfortunately, no perfect model exists, which re-
sults in a complete and specific cDC2 ablation because the
TFs regulating cDC2 development are still largely unknown
and might largely overlap with moDCs and MFs. Although
cDC2s highly express IRF4, removal of IRF4 only affects migra-
tion of cDC2s (Bajan˜a et al., 2012). Although we have recently
described Zeb2 to be a major TF for cDC2 development, Zeb2
loss only results in ablation of a proportion of cDC2s (Scott
et al., 2016).
Overall, we demonstrate that DCs in the ischemic heart are
activated and loadedwith self-antigen, licensing DCs for efficient
autoreactive T cell activation. In the future, it will be of great inter-
est to examine the activation state and function of human DCs
isolated from the infarcted heart. This could open the door for
therapeutics preventing DC maturation and self-antigen presen-
tation, which could limit the onset of pathological cardiac auto-
immunity following MI.
EXPERIMENTAL PROCEDURES
Mice
Wild-type BALB/c mice were purchased from Harlan. aMyHC-TCR transgenic
mice (TCR-M) on BALB/c background were provided by B. Ludewig and pre-
viously described (Nindl et al., 2012). Flt3l/ mice were on a C57/BL6 back-
ground. Irf4fl/fl.Cd11cCre and Irf8fl/fl.Cd11cCre were backcrossed onto the
BALB/c background for at least two generations. Mice were used between 5and 12 weeks of age. The animal ethics committee of Inflammation Research
Center (VIB-Ghent University) (IRC) approved all experiments.
Infarct Model
MI was induced by coronary artery ligation in female 8- to 12-week-old mice.
Micewere anesthetizedwith nembutal, moved in the supine position on a heat-
ing pad, and intubated. Respiration was started using positive pressure (1.5 L
90 strokes/min), and the left thoraxwas opened in between the third intercostal
space. The pericardium was opened, and the LAD was ligated proximal to the
main branching. Discoloration of the ventricle was obvious, indicating proper
LAD ligation. Sham operation incorporated all actions, except LAD ligation.
Flow Cytometric Analysis and Sorting
Organs were freshly isolated, and heart ventricles were flushed with PBS. Or-
gans were manually cut in 0.5- to 1-mm pieces using scissors. Samples were
enzymatically digested with 20 mg/mL liberase TM (Roche) and 10 U DNase
(Roche) in RPMI for 45 min at 37C. Osmotic lysis buffer was added for 3’ to
remove erythrocytes. Single-cell suspensions were incubated with amix of flu-
orescently labeled monoclonal antibodies (Abs) for 30’ at 4C. To reduce non-
specific binding, 2.4G2 Fc receptor Ab was added. An overview of Abs and
clones is found in the Supplemental Information. To identify live cells, fixable
viability dye eFluor 506 (eBioscience) was added. For intranuclear staining of
TFs, cells were fixed using a Foxp3 fixation/permeabilization kit (eBioscience).
Data were acquired on an LSR Fortessa cytometer (BD Biosciences). For cell
sorting, a FACSAria high-speed sorter (BD Biosciences) was used. Final anal-
ysis and graphical output were performed using FlowJo software (Tree Star)
and GraphPad Prism.
RNA Sequencing
cDC1s, cDC2s, moDCs, and MFs were sorted by FACS from 100 pooled
steady-state and 12 pooled infarcted hearts (7 days post-surgery) of female
WT BALB/c mice, and four independent sorts were performed. A maximum
of 25,000 cells were sorted directly into 500-mL buffer (RLT Plus; QIAGEN),
and 5-mL b-mercaptoethanol and RNA was isolated by using a micro-RNA
isolation kit (QIAGEN). Because RNA amounts were low, RNA was amplified
using SmarTER amplification (Clontech). RNA sequencing was executed at
the Nucleomics facility (VIB) using the NextSeq sequencer (Illumina). RNA-
seq was analyzed using Trimmomatic. All details are described in the Supple-
mental Information.
Adoptive Transfer of TCR-M Cells
Spleens were collected from TCR-M mice and disrupted on a 70-mm cell
strainer. Naive TCR-M splenocytes were MACS purified using the
CD4+CD62L+ T Cell isolation kit (Miltenyi). TCR-M cells were labeled with
CFSE (Invitrogen). 1 3 106 naive TCR-M T cells were injected intravenously
in the lateral tail vein of sham-operated and infarcted mice at day 2 and day
7 after surgery. 3 days after TCR-M adoptive transfer, mice were sacrificed,
lymphoid organs were isolated, and cell suspensions were prepared as
described for the spleen. CFSE dilution and T cell activation were evaluated
by flow cytometry.
Ex Vivo Bulk Lymph Node Co-cultures
Lymph nodes were collected frommice at day 2 or day 7 post surgery. Single-
cell suspensions were prepared as described above. 2.5 3 105 bulk LN cells
were added to 5 3 104 MACS purified naive CD4+CD62Lhi TCR-M cells that
were CFSE labeled. CFSE dilution and T cell activation were evaluated by
flow cytometry after 3 days of incubation at 37C, 5% CO2, and 20% O2.
Ex vivo Co-cultures of Sorted DC Subsets and TCR-M Cells
TCR-M cells were purified from the spleen using the CD4+ T Cell isolation kit
(Miltenyi) and labeled with CFSE. 5 3 104 TCR-M cells were co-cultured
with 1 3 104 FACS-sorted cDC1s, cDC2s, and moDCs from the mediastinal,
mesenteric LN, or heart of sham and MI mice (day 7). CFSE dilution and
T cell activation were evaluated by flow cytometry after 4 days of incubation
at 37C, 5% CO2, and 20% O2. To check Th skewing of TCR-M cells, IL-
17A and IFNg ELISA (eBioscience, Ready-Set-Go kit) was performed on the
co-culture cell supernatants.Cell Reports 18, 3005–3017, March 21, 2017 3015
Statistical Analysis
For all experiments, the difference between groups was calculated using the
Mann-WhitneyU test for unpaired data (GraphPad Prism) and was considered
significant when p < 0.05.
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